Streamlining Cigna Eliquis Prior Authorization

Navigating Cigna Eliquis prior authorization can be a significant administrative burden, impacting patient access to critical direct oral anticoagulants. Klivira streamlines this process, connecting directly with Evernorth's pharmacy benefit manager for efficient approvals.

For revenue cycle directors and prior authorization coordinators, managing high-volume drug PAs like Eliquis (apixaban) requires precision and efficiency. Understanding Cigna Healthcare's specific requirements, from formulary adherence to submission channels, is crucial for minimizing denials and accelerating patient care. Our platform is designed to automate these complexities.

Understanding Eliquis (Apixaban) Prior Authorization with Cigna

Eliquis, a direct oral anticoagulant (DOAC), is commonly prescribed for indications such as atrial fibrillation and venous thromboembolism (VTE). Due to its cost and clinical profile, Cigna Healthcare often requires prior authorization, frequently involving step therapy protocols against alternatives like warfarin or other DOACs. Klivira integrates with payer-specific logic to flag these requirements proactively.

Cigna's Pharmacy Benefit and Eliquis PA Submission Channels

For pharmacy-benefit drugs like Eliquis, prior authorization requests for Cigna Healthcare members are managed by Evernorth's pharmacy benefit manager, Express Scripts. Klivira facilitates electronic prior authorization (ePA) submissions through established industry channels, including CoverMyMeds and Surescripts, directly to Express Scripts' provider PA system. This ensures a consistent and auditable submission pathway for apixaban.

Accessing Cigna Healthcare's Eliquis Coverage Policies

Cigna Healthcare publishes its coverage policies and medical necessity guidelines on its public provider site. These policies are versioned and dated, outlining specific clinical criteria, step therapy requirements, and quantity limits for drugs like Eliquis. Klivira's platform can be configured to reference these specific policies, ensuring submitted documentation aligns with Cigna's latest criteria.

Common Denial Reasons for Eliquis with Cigna Healthcare

Typical denial reasons for Eliquis prior authorizations under Cigna Healthcare include failure to meet step therapy requirements (e.g., not documenting a trial of warfarin), insufficient documentation of medical necessity for indicated conditions, or non-formulary pharmacy denials related to the Express Scripts formulary. Klivira's pre-submission logic helps identify and mitigate these common pitfalls.

Cigna PA Turnaround Times and CMS-0057-F Compliance

Cigna Healthcare's commercial prior authorization turnaround times are dictated by state insurance regulations. For Medicare Advantage and Qualified Health Plans on the FFM, Cigna is an impacted payer under CMS-0057-F, which mandates 72-hour standard and 24-hour expedited PA timeframes. Klivira helps track and manage submissions within these critical windows, improving compliance and patient access.

Frequently asked questions

How does Cigna Healthcare manage Eliquis prior authorizations?

For Eliquis, Cigna Healthcare utilizes Evernorth's Express Scripts as its pharmacy benefit manager. Prior authorization requests are routed through Express Scripts' provider PA system, often via ePA partners like CoverMyMeds and Surescripts, to assess formulary adherence and medical necessity.

What are common step therapy requirements for Eliquis under Cigna?

Cigna Healthcare's formulary often requires step therapy for Eliquis (apixaban), meaning a trial of a less expensive or preferred anticoagulant, such as warfarin, may be necessary before Eliquis is approved. Documentation of failure or contraindication to these alternatives is typically required.

Where can I find Cigna's specific coverage policies for Eliquis?

Cigna Healthcare publishes its detailed coverage policies and medical necessity guidelines on its public provider website. These documents outline the clinical criteria, indications, and any specific documentation required for Eliquis authorization, including policy numbers and effective dates.

Does CMS-0057-F apply to Cigna Eliquis prior authorizations?

Yes, for Cigna Healthcare's Medicare Advantage and Qualified Health Plans on the Federal Facilitated Marketplace, CMS-0057-F mandates specific turnaround times for prior authorizations, including for medications like Eliquis. This rule requires 72-hour standard and 24-hour expedited PA decisions.